Clinical Development

The Clinical Development and Medical Affairs (CDMA) team at Biocon Biologics is pivotal to the success of our biosimilar strategy, driving the execution of high-quality clinical trials. The key arms of the clinical development function— Clinical Sciences, Biostatistics, Clinical Operations, Pharmacovigilance, Medical Communication, Quality & Compliance, and Global Medical Affairs — work in tandem to ensure that our biosimilars meet rigorous scientific and regulatory standards, to reach the market in a timely and cost-effective manner.

Clinical Development

Global Medical Affairs

The Global Medical Affairs team bridges the gap between Biocon Biologics and the healthcare community by delivering accurate, up-to-date scientific data on our biosimilars.

The team is responsible for educating healthcare professionals (HCPs) on the potential of biosimilars to promote equitable care and sustainability, playing a pivotal role in advancing the scientific and clinical understanding of our biosimilars and biologics portfolio. In addition to supporting the development of clinical guidelines in close collaboration with regulatory bodies, it leads key medical education initiatives, including webinars and scientific conferences, to foster knowledge exchange and drive innovation. 

Through active engagement with Key Opinion Leaders (KOLs) and stakeholders, Global Medical Affairs facilitates collaboration, shares clinical insights, and drives confidence in the adoption of biosimilars, for improved patient care.

Related Links

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Leaving the Biocon Biologics site

You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.